Trial Profile

Usage of Vinflunine i.v. (JAVLOR) for the Treatment of Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium in Adult Patients After Failure of a Cisplatinum-containing Therapy

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 07 Oct 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vinflunine (Primary)
Indications Carcinoma; Urogenital cancer
Focus Adverse reactions
Acronyms JONAS-1
Sponsors Pierre Fabre

Most Recent Events

27 Oct 2017 Results of post hoc subgroup (upper tract versus lower tract metastatic urothelial carcinomas) analysis published in the Anticancer Research
02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
11 Dec 2013 Status changed from active, no longer recruiting to recruiting as reported by German Clinical Trials Register.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com